Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28M Sell
77,424
-1,492
-2% -$511K 0.32% 78
2026
Q1
$27.8M Buy
78,916
+1,150
+1% +$410K 0.35% 72
2025
Q4
$25.5M Sell
77,766
-1,171
-1% -$371K 0.32% 74
2025
Q3
$22.3M Sell
78,937
-152
-0.2% -$44.1K 0.29% 83
2025
Q2
$22.1M Buy
+79,089
New +$22.4M 0.31% 82

Other funds holding AMGN

Midwest Trust's AMGN Position: Q2 2026 in Review

Midwest Trust reduced its Amgen (AMGN) stake by 1.9% in Q2 2026, selling an estimated $511K and leaving 77,424 shares worth $28M. The position accounts for 0.32% of the portfolio, ranked #78.

Midwest Trust first reported a position in AMGN in Q2 2025 and has held it in 5 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Midwest Trust held 77,424 shares of Amgen worth $28M as of Q2 2026.
  • Midwest Trust sold 1,492 Amgen shares in Q2 2026, an estimated $511K.
  • Amgen made up 0.32% of Midwest Trust's portfolio in Q2 2026, its #78 holding.
  • Midwest Trust first reported a position in Amgen in Q2 2025 and has held it in 5 quarters since.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Midwest Trust's 13F filing for Q2 2026, filed 5 Aug 2026.